Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature

In the era of precision medicine, cancer therapy can be tailored to an individual patient based on the genomic profile of a tumour. Despite the ever-increasing abundance of cancer genomic data, linking mutation profiles to drug efficacy remains a challenge. Herein, we report Cancer Drug Response pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yoosup, Park, Hyejin, Yang, Hyun-Jin, Lee, Seungju, Lee, Kwee-Yum, Kim, Tae Soon, Jung, Jongsun, Shin, Jae-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996063/
https://www.ncbi.nlm.nih.gov/pubmed/29891981
http://dx.doi.org/10.1038/s41598-018-27214-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996063/
https://www.ncbi.nlm.nih.gov/pubmed/29891981
http://dx.doi.org/10.1038/s41598-018-27214-6

Ejemplares similares